Clinical significance of a borderline titer in a negative ELISA test for heparin-induced thrombocytopenia

Majed A. Refaai, Michael Laposata, Elizabeth M. Van Cott

Research output: Contribution to journalArticle

19 Citations (Scopus)

Abstract

We studied the usefulness of repeated enzyme-linked immunosorbent assay testing for heparin-induced thrombocytopenia (HIT) when the initial test result was negative and sought to determine whether the titer of the initial negative result correlated with the likelihood of obtaining a positive test result in repeated testing. We divided 150 patients who underwent HIT testing into 3 groups (50 patients each): (1) very low titer negative (0.0%-33.3% of the threshold for a positive test); (2) low titer negative (33.4%-66.6% of the threshold); and (3) high titer negative (66.7%-99.9% of the threshold). Among the patients who underwent a repeat test, 5% (1/20) of group 1 patients, 13% (4/32) of group 2 patients, and 43% (13/30) of group 3 patients tested positive in the repeat test (P = .0026). Thus, nearly half of patients with initially negative HIT test results had positive results in the repeat test if the negative titer was 66.7% or more of the threshold. If laboratories report the HIT titer, rather than just negative or positive, the titer might help clinicians predict which patients have HIT despite a negative initial test, and the overall sensitivity for diagnosing HIT might be improved.

Original languageEnglish (US)
Pages (from-to)61-65
Number of pages5
JournalAmerican Journal of Clinical Pathology
Volume119
Issue number1
DOIs
StatePublished - Jan 1 2003
Externally publishedYes

Fingerprint

Thrombocytopenia
Heparin
Enzyme-Linked Immunosorbent Assay

Keywords

  • ELISA
  • Heparin
  • Heparin-induced thrombocytopenia
  • HIT titer
  • Platelet count
  • Thrombocytopenia
  • Thrombosis

ASJC Scopus subject areas

  • Pathology and Forensic Medicine

Cite this

Clinical significance of a borderline titer in a negative ELISA test for heparin-induced thrombocytopenia. / Refaai, Majed A.; Laposata, Michael; Van Cott, Elizabeth M.

In: American Journal of Clinical Pathology, Vol. 119, No. 1, 01.01.2003, p. 61-65.

Research output: Contribution to journalArticle

@article{4b6ed842d1ef4e05bda6b864b4a35fef,
title = "Clinical significance of a borderline titer in a negative ELISA test for heparin-induced thrombocytopenia",
abstract = "We studied the usefulness of repeated enzyme-linked immunosorbent assay testing for heparin-induced thrombocytopenia (HIT) when the initial test result was negative and sought to determine whether the titer of the initial negative result correlated with the likelihood of obtaining a positive test result in repeated testing. We divided 150 patients who underwent HIT testing into 3 groups (50 patients each): (1) very low titer negative (0.0{\%}-33.3{\%} of the threshold for a positive test); (2) low titer negative (33.4{\%}-66.6{\%} of the threshold); and (3) high titer negative (66.7{\%}-99.9{\%} of the threshold). Among the patients who underwent a repeat test, 5{\%} (1/20) of group 1 patients, 13{\%} (4/32) of group 2 patients, and 43{\%} (13/30) of group 3 patients tested positive in the repeat test (P = .0026). Thus, nearly half of patients with initially negative HIT test results had positive results in the repeat test if the negative titer was 66.7{\%} or more of the threshold. If laboratories report the HIT titer, rather than just negative or positive, the titer might help clinicians predict which patients have HIT despite a negative initial test, and the overall sensitivity for diagnosing HIT might be improved.",
keywords = "ELISA, Heparin, Heparin-induced thrombocytopenia, HIT titer, Platelet count, Thrombocytopenia, Thrombosis",
author = "Refaai, {Majed A.} and Michael Laposata and {Van Cott}, {Elizabeth M.}",
year = "2003",
month = "1",
day = "1",
doi = "10.1309/6922EWGPHVDX9EQJ",
language = "English (US)",
volume = "119",
pages = "61--65",
journal = "American Journal of Clinical Pathology",
issn = "0002-9173",
publisher = "American Society of Clinical Pathologists",
number = "1",

}

TY - JOUR

T1 - Clinical significance of a borderline titer in a negative ELISA test for heparin-induced thrombocytopenia

AU - Refaai, Majed A.

AU - Laposata, Michael

AU - Van Cott, Elizabeth M.

PY - 2003/1/1

Y1 - 2003/1/1

N2 - We studied the usefulness of repeated enzyme-linked immunosorbent assay testing for heparin-induced thrombocytopenia (HIT) when the initial test result was negative and sought to determine whether the titer of the initial negative result correlated with the likelihood of obtaining a positive test result in repeated testing. We divided 150 patients who underwent HIT testing into 3 groups (50 patients each): (1) very low titer negative (0.0%-33.3% of the threshold for a positive test); (2) low titer negative (33.4%-66.6% of the threshold); and (3) high titer negative (66.7%-99.9% of the threshold). Among the patients who underwent a repeat test, 5% (1/20) of group 1 patients, 13% (4/32) of group 2 patients, and 43% (13/30) of group 3 patients tested positive in the repeat test (P = .0026). Thus, nearly half of patients with initially negative HIT test results had positive results in the repeat test if the negative titer was 66.7% or more of the threshold. If laboratories report the HIT titer, rather than just negative or positive, the titer might help clinicians predict which patients have HIT despite a negative initial test, and the overall sensitivity for diagnosing HIT might be improved.

AB - We studied the usefulness of repeated enzyme-linked immunosorbent assay testing for heparin-induced thrombocytopenia (HIT) when the initial test result was negative and sought to determine whether the titer of the initial negative result correlated with the likelihood of obtaining a positive test result in repeated testing. We divided 150 patients who underwent HIT testing into 3 groups (50 patients each): (1) very low titer negative (0.0%-33.3% of the threshold for a positive test); (2) low titer negative (33.4%-66.6% of the threshold); and (3) high titer negative (66.7%-99.9% of the threshold). Among the patients who underwent a repeat test, 5% (1/20) of group 1 patients, 13% (4/32) of group 2 patients, and 43% (13/30) of group 3 patients tested positive in the repeat test (P = .0026). Thus, nearly half of patients with initially negative HIT test results had positive results in the repeat test if the negative titer was 66.7% or more of the threshold. If laboratories report the HIT titer, rather than just negative or positive, the titer might help clinicians predict which patients have HIT despite a negative initial test, and the overall sensitivity for diagnosing HIT might be improved.

KW - ELISA

KW - Heparin

KW - Heparin-induced thrombocytopenia

KW - HIT titer

KW - Platelet count

KW - Thrombocytopenia

KW - Thrombosis

UR - http://www.scopus.com/inward/record.url?scp=85047688615&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85047688615&partnerID=8YFLogxK

U2 - 10.1309/6922EWGPHVDX9EQJ

DO - 10.1309/6922EWGPHVDX9EQJ

M3 - Article

VL - 119

SP - 61

EP - 65

JO - American Journal of Clinical Pathology

JF - American Journal of Clinical Pathology

SN - 0002-9173

IS - 1

ER -